Experimental Mice Study Shows CBD May Reduce Plaque and Improve Cognition in Familial Alzheimer’s Model
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an experimental mouse study in the Journal of Alzheimer’s Disease shows that a two-week course of CBD may reduce plaque and improve cognition. Researchers tested aRead
